U.S. diagnostic testing providers are navigating post-pandemic normalization, leaning on routine testing and hospital laboratory management deals to drive volumes amid sustained reimbursement pressure and elevated labor costs.
U.S. diagnostic testing providers are navigating post-pandemic normalization, leaning on routine testing and hospital laboratory management deals to drive volumes amid sustained reimbursement pressure and elevated labor costs.